Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells

Go back to Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells
(NASDAQ: AUTL) Delayed: 1.64 +0.05 (3.14%)
Previous Close $1.59    52 Week High
Open $1.61    52 Week Low
Day High $1.66    P/E N/A 
Day Low $1.61    EPS
Volume 62,458